The Experts below are selected from a list of 312 Experts worldwide ranked by ideXlab platform
Christian Gortázar - One of the best experts on this subject based on the ideXlab platform.
-
no effect of inoculation site and Injection Device on the skin test response of red deer to the intradermal Injection of mycobacterium avium derived purified protein derivative ppd
Preventive Veterinary Medicine, 2020Co-Authors: Julio Isla, Jose Antonio Ortiz, Mariana Boadella, Christian GortázarAbstract:Abstract Mycobacterial diseases are important health issues in farmed deer. The single intradermal tuberculin test is the standard test for tuberculosis testing in deer. We studied two factors which might influence the response of deer to skin testing: the inoculation site and the Injection Device. Deer included in this study were 2.5 years old farmed red deer (Cervus elaphus) hinds (n = 80). Two areas of 3 cm × 3 cm were shaved at the left side of the neck. Site A (SA) was situated about 10 cm caudal to the head, while site B (SB) was 10 cm caudal to SA. All hinds received at the same time two 0.1 ml inoculations of Mycobacterium avium derived purified protein derivative (aPPD). One inoculation was made by syringe and the other one with the needle-free syringe Dermojet. To test the inoculation site effect, half of the animals were inoculated by Dermojet in SA and by syringe in SB to compare with the inoculation in SA by syringe and Dermojet in SB in the other half. No differences were recorded for the Injection Device nor for the inoculation site. Ten hinds had a skinfold increase larger than 30 tenths of mm by any Injection Device and inoculation site. Seven (9%) and 6 (8%) hinds were classified as positive by syringe and Dermojet, and at the anterior or posterior inoculation site, respectively. The distribution of skinfold thickness increases did not differ by Injection Device. Our findings support the needle-free Dermojet syringe as a suitable tool for skin-testing in red deer and suggest no relevant effect of the position of the inoculation site along the neck in red deer.
Julio Isla - One of the best experts on this subject based on the ideXlab platform.
-
no effect of inoculation site and Injection Device on the skin test response of red deer to the intradermal Injection of mycobacterium avium derived purified protein derivative ppd
Preventive Veterinary Medicine, 2020Co-Authors: Julio Isla, Jose Antonio Ortiz, Mariana Boadella, Christian GortázarAbstract:Abstract Mycobacterial diseases are important health issues in farmed deer. The single intradermal tuberculin test is the standard test for tuberculosis testing in deer. We studied two factors which might influence the response of deer to skin testing: the inoculation site and the Injection Device. Deer included in this study were 2.5 years old farmed red deer (Cervus elaphus) hinds (n = 80). Two areas of 3 cm × 3 cm were shaved at the left side of the neck. Site A (SA) was situated about 10 cm caudal to the head, while site B (SB) was 10 cm caudal to SA. All hinds received at the same time two 0.1 ml inoculations of Mycobacterium avium derived purified protein derivative (aPPD). One inoculation was made by syringe and the other one with the needle-free syringe Dermojet. To test the inoculation site effect, half of the animals were inoculated by Dermojet in SA and by syringe in SB to compare with the inoculation in SA by syringe and Dermojet in SB in the other half. No differences were recorded for the Injection Device nor for the inoculation site. Ten hinds had a skinfold increase larger than 30 tenths of mm by any Injection Device and inoculation site. Seven (9%) and 6 (8%) hinds were classified as positive by syringe and Dermojet, and at the anterior or posterior inoculation site, respectively. The distribution of skinfold thickness increases did not differ by Injection Device. Our findings support the needle-free Dermojet syringe as a suitable tool for skin-testing in red deer and suggest no relevant effect of the position of the inoculation site along the neck in red deer.
Mariana Boadella - One of the best experts on this subject based on the ideXlab platform.
-
no effect of inoculation site and Injection Device on the skin test response of red deer to the intradermal Injection of mycobacterium avium derived purified protein derivative ppd
Preventive Veterinary Medicine, 2020Co-Authors: Julio Isla, Jose Antonio Ortiz, Mariana Boadella, Christian GortázarAbstract:Abstract Mycobacterial diseases are important health issues in farmed deer. The single intradermal tuberculin test is the standard test for tuberculosis testing in deer. We studied two factors which might influence the response of deer to skin testing: the inoculation site and the Injection Device. Deer included in this study were 2.5 years old farmed red deer (Cervus elaphus) hinds (n = 80). Two areas of 3 cm × 3 cm were shaved at the left side of the neck. Site A (SA) was situated about 10 cm caudal to the head, while site B (SB) was 10 cm caudal to SA. All hinds received at the same time two 0.1 ml inoculations of Mycobacterium avium derived purified protein derivative (aPPD). One inoculation was made by syringe and the other one with the needle-free syringe Dermojet. To test the inoculation site effect, half of the animals were inoculated by Dermojet in SA and by syringe in SB to compare with the inoculation in SA by syringe and Dermojet in SB in the other half. No differences were recorded for the Injection Device nor for the inoculation site. Ten hinds had a skinfold increase larger than 30 tenths of mm by any Injection Device and inoculation site. Seven (9%) and 6 (8%) hinds were classified as positive by syringe and Dermojet, and at the anterior or posterior inoculation site, respectively. The distribution of skinfold thickness increases did not differ by Injection Device. Our findings support the needle-free Dermojet syringe as a suitable tool for skin-testing in red deer and suggest no relevant effect of the position of the inoculation site along the neck in red deer.
Jose Antonio Ortiz - One of the best experts on this subject based on the ideXlab platform.
-
no effect of inoculation site and Injection Device on the skin test response of red deer to the intradermal Injection of mycobacterium avium derived purified protein derivative ppd
Preventive Veterinary Medicine, 2020Co-Authors: Julio Isla, Jose Antonio Ortiz, Mariana Boadella, Christian GortázarAbstract:Abstract Mycobacterial diseases are important health issues in farmed deer. The single intradermal tuberculin test is the standard test for tuberculosis testing in deer. We studied two factors which might influence the response of deer to skin testing: the inoculation site and the Injection Device. Deer included in this study were 2.5 years old farmed red deer (Cervus elaphus) hinds (n = 80). Two areas of 3 cm × 3 cm were shaved at the left side of the neck. Site A (SA) was situated about 10 cm caudal to the head, while site B (SB) was 10 cm caudal to SA. All hinds received at the same time two 0.1 ml inoculations of Mycobacterium avium derived purified protein derivative (aPPD). One inoculation was made by syringe and the other one with the needle-free syringe Dermojet. To test the inoculation site effect, half of the animals were inoculated by Dermojet in SA and by syringe in SB to compare with the inoculation in SA by syringe and Dermojet in SB in the other half. No differences were recorded for the Injection Device nor for the inoculation site. Ten hinds had a skinfold increase larger than 30 tenths of mm by any Injection Device and inoculation site. Seven (9%) and 6 (8%) hinds were classified as positive by syringe and Dermojet, and at the anterior or posterior inoculation site, respectively. The distribution of skinfold thickness increases did not differ by Injection Device. Our findings support the needle-free Dermojet syringe as a suitable tool for skin-testing in red deer and suggest no relevant effect of the position of the inoculation site along the neck in red deer.
Maria J Redondo - One of the best experts on this subject based on the ideXlab platform.
-
what can we learn from patient reported outcomes of insulin pen Devices
Journal of diabetes science and technology, 2011Co-Authors: Barbara J Anderson, Maria J RedondoAbstract:Although a variety of effective treatment options are available for patients with type 1 or type 2 diabetes, many patients in the United States have difficulty reaching their glycemic goals. Patient adherence to insulin therapy, which often involves self-administered subcutaneous Injections of insulin using either a vial and syringe or an insulin pen Device, is often poor. Various factors associated with the type of Injection Device have been shown to influence the rate of patient adherence to insulin therapy. This article reviews patient-reported outcome (PRO) evidence from pediatric and adult studies that compared insulin pen Devices with vial and syringe use. In a majority of these cases, patients preferred the pen Devices over vial and syringe, stating advantages such as ease of use, convenience, greater confidence in their ability to properly administer the drug, and a greater perceived social acceptance. The pens were considered less painful than syringes and were associated with less needle fear. In addition, PRO evidence has directed pen technology design, leading to development of more advanced insulin pen Devices. By appreciating the correlation between adherence to insulin regimens and a patient’s Device preference, clinicians can make improved treatment recommendations to facilitate achievement and maintenance of glycemic targets.